Novel Therapies for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

The most common type of non-Hodgkin lymphoma in adults is diffuse large B-cell (DLBCL). There is a historical unmet need for more effective therapies in the 2nd and 3rd line setting. Emerging immunochemotherapies have shown activity in small studies of heavily pre-treated patients with prolonged rem...

Descripción completa

Detalles Bibliográficos
Autores principales: Harris, Leonard Jeff, Patel, Kruti, Martin, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698117/
https://www.ncbi.nlm.nih.gov/pubmed/33202794
http://dx.doi.org/10.3390/ijms21228553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698117/
https://www.ncbi.nlm.nih.gov/pubmed/33202794
http://dx.doi.org/10.3390/ijms21228553

Ejemplares similares